Skip to main content
SpringerLink
Log in

Cost-effectiveness analysis of strategies for screening prostatic cancer

  • Chapter
Health Economics Worldwide

Part of the book series: Developments in Health Economics and Public Policy ((HEPP,volume 1))

Abstract

A screening programme is justified if it fulfils three criteria: the disease incidence is high, the natural course is known and effective treatment exists. If we confine ourselves to the first criterion, then screening for cancer of the prostate seems an absolute necessity. In 1982, 27% of the 282,660 male deaths recorded in France were due to cancer. Prostate cancer accounted for 1 in 10 cases. In other terms, 2.5% of deaths among the male population is caused by a malignant tumour of the prostate, which corresponds to a crude mortality rate in France of 27 per 100,000. On the international level, statistics show that the problem is at least as acute in the other Western countries. The rate of mortality standardized for the world population reaches 14.7 per 100,000 in the United States, versus 15 per 100,000 in France. The crude rate of incidence for the Americans is three times greater than the crude rate of mortality in the country. According to Silverberg (1987), 1 American out of 11 (8.7%) born in 1985 risks developing cancer of the prostate during the course of his life. The risk is as great as for lung cancer. On the other hand, however, it should be noted that if 90% of lung cancer patients die from their disease, death from cancer of the prostate occurs in one case out of three.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Beck, R., Kassirer, J., Pauker, S., (1982). A convenient approximation of life expectancy (The Deale) used in decision-making. Am J Med, 73: 889–897.

    Article  Google Scholar 

  • Begg, C., Greenes, R., (1983) Assesment of diagnostic test when disease verification is subject to selection bias. Biometrics, 39: 207–215.

    Article  Google Scholar 

  • Begg, C., Greenes, R., Iglewicz, B., (1986) The influence of uninterpretability on the assessment of diagnostic tests. J Chron Dis, 39, 8: 575–584.

    Article  Google Scholar 

  • Begg, C, McNeil, B., (1988) Assessment of radiologic tests: control of bias and other design considerations. Radiology, 167: 565–569.

    Google Scholar 

  • Boccon-Gibod, L., (1988) Le dépistage du cancer de la prostate, défi de la décennie 1990. An Urolll 6: 385–387.

    Google Scholar 

  • Chodak, G., Keller, P., Schoenberg, H., (1989) Assessment of screening for prostate cancer using the digital rectal examination. The J of Urol, 141: 1136–1138.

    Google Scholar 

  • Cooner, W., Mosley, B., Rutherford, C. et al. (1989) Coordination of urosonography and prostate-specific antigen in the diagnosis of non-palpable prostate cancer. J of Endour, 3: 19–25.

    Article  Google Scholar 

  • Devonec, M., Fendler, J.P., Monsalier, M., et al. (1990) The significance of the prostatic hypoechoic area: results in 226 ultrasonically guided prostatic biopsies. J of Urol, 143: 316–319.

    Google Scholar 

  • Edwards, C., Steinthorsson, E., Nicholson, D., (1952) An autopsy study of latent prostatic cancer. Cancer, 6: 531–554.

    Article  Google Scholar 

  • England, W., Halls, J., Hunt, V., (1989) Strategies for screening for colorectal carcinoma. Med Decis making, 9: 3–13.

    Article  Google Scholar 

  • Faul, P., (1982) Experience of a German annual preventive check-up examination. International Perspectives in Urology 3 Prostate Cancer. Ed. Jacobi, G. and Hohenfellner R., Williams and Wilkins, Baltimore.

    Google Scholar 

  • Feldman, A., Kessler, L., Myers, M., and al. (1986) The prevalence of cancer: estimates based on the Connecticut tumour registry. N Engl J of Med, 315: 1394–1397.

    Article  Google Scholar 

  • Franks, L.M., (1954) Latent carcinoma of the prostate. J Path Bact v, 8: 603–6166.

    Article  Google Scholar 

  • Gilbertsen, V., (1971) Cancer of the prostate gland. Jama, 215: 81–84.

    Article  Google Scholar 

  • Gleason, D.J., (1966) Classification of prostatic carcinomas. Cancer chimiotherapy reports, 50: 125–128.

    Google Scholar 

  • Guinan, P., (1980) The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Eng J Med, 303: 499–503.

    Article  Google Scholar 

  • Guillaume, M., (1971) La valeur de la vie humaine dans le choix des investissements routiers. Revue Rationnalisation des choix budgétaires, (septembre): 48–58.

    Google Scholar 

  • Hermanek, P., Sobin, L., (1988) TNM classification des tumeurs malignes. Springer-Verlag, Ed. France.

    Google Scholar 

  • Holund, B., (1980) Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol, 14: 29–35.

    Article  Google Scholar 

  • Hudson, P., Finkle, A., Hopkins, J., et al. (1954) Early prostatic cancer diagnosed by arbitrary open perineal biopsy among 300 unselected patients. Cancer, 7: 690–703.

    Article  Google Scholar 

  • International Histological Classification of Tumours (1980) n° 22, Histological typing of prostate tumours, Geneva: WHO.

    Google Scholar 

  • Imai, K., Zimbo, K., Shimizu, K., and al. (1988) Clinical Characteristics of prostatic cancer detected by mass screening. The prostate, 12: 199–207.

    Article  Google Scholar 

  • Johansson, J., Andersson, S., Krusemo, U., et al. (1989) Natural History of localized prostatic cancers. A population based study in 223 untreated patients Lancet, i 15: 799–803.

    Article  Google Scholar 

  • Kabalin, J., McNeal, J., Price, H., et al. (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometries observations. The J of Urol, 141: 1093–1094.

    Google Scholar 

  • Lee, F., Littrup, P., Torp-Pedersen, S., (1988) Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology, 168: 389–394.

    Google Scholar 

  • Lee, F., Torp-Pedersen, S., Littrup, P., et al. (1989) Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination and prostate-specific antigen. Radiology, 170: 29–32.

    Google Scholar 

  • Lepor, H., Kimball, A., Walsh, P., (1989) Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate. The J of Urol, 141: 82–84.

    Google Scholar 

  • Montie, E., Wood, P., Pontes, J., (1989) Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer, 63: 381–385.

    Article  Google Scholar 

  • Mueller, E., Craint, T., Thompson, I., et al. (1988) An evaluation of serial digital examination in screening for prostate cancer The J of Urol, 141: 1445–1447.

    Google Scholar 

  • Perrin, P., Maquet, J.H., (1989) Screening for prostate cancer, a European experience. Research paper accepted for publication in Br J of Urol.

    Google Scholar 

  • Pritchett, T., Moreno, J., Warner, N., et al. (1988) Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. The J of Urol, 139: 1214–1216.

    Google Scholar 

  • Ransohoff, D., Feinstein, A., (1978) Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J of Med, 299: 906–930.

    Article  Google Scholar 

  • Scott, R., Mutchnick, D., Laskowski, T., (1969) Carcinoma of the prostate in elderly men: incidence, growth, characteristics and clinical significance. The J of Urol, 101: 603–607.

    Google Scholar 

  • Sheldon, C, Williams, R.D., Fraley, E.E. (1980) Incidental carcinoma of the prostate: review of literature and critical reappraisal of classification. The J of Urol, 124: 626–631.

    Google Scholar 

  • Silverberg, E., (1987) Statistical and epidemiologic data on urologie cancer. Cancer, 60: 692–716.

    Article  Google Scholar 

  • Stamey, T.A., McNeal, J.E., (1987) Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med, 317: 909–16.

    Article  Google Scholar 

  • Teillac, P., Bron, J., Tobolski, F., et al. (1990) Dépistage du cancer de la prostate: étude de 600 cas. Ann Urol, 24: 37–41.

    Google Scholar 

  • Thompson, I., Ernst, J., Gangai, M., et al. (1984) Adenocarcinoma of the prostate: results of routine urological screening. The J of Urol, 132: 690–692.

    Google Scholar 

  • Vallancien, G., Prapotnich, D., Sibert, L., (1989) Comparison of the efficacy of digital rectal examination and transrectal ultrasonography in the diagnosis of prostatic cancer. European Urol, 16: 321–324.

    Google Scholar 

  • Vallancien, G., Prapotnich, D., Veillon, B., (1990) Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. Accepted for publication in the J of Urol.

    Google Scholar 

  • Vihko, P., Kontturi, M., Lukkarinen, O., et al. (1985) Screening for carcinoma of the prostate. Cancer, 56: 173–177.

    Article  Google Scholar 

  • Whitmore, W., (1984) Natural history and staging of prostate cancer. Urology clinics of North-America, 11: 205–220.

    Google Scholar 

  • Whitmore, W., (1988) Overview: historical and contemporary in Consensus Development Conference on the Management of Clinically Localized Prostate Cancer. National NCI monographs n° 7: 7–11.

    Google Scholar 

  • Winder, E., Mabuchi, K., Whitmore, W., (1971) Epidemiology of cancer of the prostate. Cancer, 28 2: 344–359.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UFR de Bobigny, Université de Paris Nord, France

    R. Launois

Authors
  1. R. Launois
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. of Economics, University of Zürich, Switzerland

    Peter Zweifel

  2. Dept. of Economics, University of California, USA

    H. E. Frech III

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Launois, R. (1992). Cost-effectiveness analysis of strategies for screening prostatic cancer. In: Zweifel, P., Frech, H.E. (eds) Health Economics Worldwide. Developments in Health Economics and Public Policy, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2392-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-2392-1_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5055-5

  • Online ISBN: 978-94-011-2392-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation